tm logo
Trademark Search
V VERITY PHARMACEUTICALS & Design

View On IC.GC.CA

V VERITY PHARMACEUTICALS & Design
REGISTERED

on 15 Nov 2024

Last Applicant/ Owned by

Verity Pharmaceuticals Inc.

2560 Matheson Blvd. East, Suite 220Mississauga

ONTARIO

CA

L4W4Y9

Serial Number

2062890 filed on 10th Nov 2020

Registration Number

TMA1269613 registered on 15th Nov 2024

Registration expiry Date

15th Nov 2034

Correspondent Address

INTELLECTUAL PROPERTY GROUPSUITE 4000, COMMERCE COURT WEST199 BAY STREETTORONTO

ONTARIO

CA

M5L1A9

V VERITY PHARMACEUTICALS & Design

Trademark usage description

pharmaceuticals for the treatment of oncological and genitourinary disease, disorders, and conditions; anesthesia preparations for use in the fields o Read More

Classification Information

Class [005]
Pharmaceuticals for the treatment of oncological and genitourinary disease, disorders, and conditions; anesthesia preparations for use in the fields of dentistry and surgery; pharmaceutical preparations for maintaining normal blood pressure and heart function; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for treating allergies; pharmaceuticals for use in dermatology; pharmaceuticals for use in diagnostic radiology, namely, radiological contrast substances; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the treatment of diseases, disorders and infections affecting the metabolic system; pharmaceutical preparations for the treatment of kidney diseases; pharmaceuticals for use in gastroenterology; pharmaceuticals for use in hematology; pharmaceuticals for use in infectious diseases, namely, respiratory infections, eye infections, topical infections, bacterial meningitis, bone and joint infections, intra-abdominal infections, skin and soft tissue infections, urinary tract infections, pneumonia, infective endocarditis, bacteremia, lung infections, kidney infections, bladder infections, brain infections, and blood infections; pharmaceuticals for use in medical oncology; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; radiopharmaceuticals; pharmaceuticals for use in the treatment of disorders relating to sexual reproduction and fertility; pharmaceuticals for use in ophthalmology; pharmaceuticals for use in radiation oncology; pharmaceuticals for use in respirology; pharmaceuticals for the treatment of bone diseases; pharmaceutical preparations for the treatment of diseases affecting the ears, nose and throat, namely, ear infections, strep throat, sinusitis, and sleep apnea; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; pharmaceuticals for use in urology

Classification kind code

11

Mark Details

Serial Number

2062890

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 27
on 30th Jul 2024		Approval Notice Sent
Submitted for opposition 15
on 19th Jan 2024		Correspondence Created
Submitted for opposition 22
on 20th Jul 2023		Search Recorded
Submitted for opposition 20
on 20th Jul 2023		Examiner's First Report
Submitted for opposition 287
on 22nd Jun 2022		Pre-Assessment Letter Sent
Submitted for opposition 89
on 19th Oct 2021		Security Interest Removed
Submitted for opposition 88
on 10th Feb 2021		Security Interest Placed
Submitted for opposition 30
on 10th Nov 2020		Filed
Submitted for opposition 1
on 10th Nov 2020		Created
Submitted for opposition 31
on 10th Nov 2020		Formalized